Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Therapy Name||APG-2575 + unspecified immune checkpoint inhibitor|
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|APG-2575||APG 2575|APG2575||BCL2 inhibitor 23||APG-2575 is a small molecule that inhibits BCL-2, potentially resulting in increased apoptosis and enhanced antitumor activity in combination with other agents (Cancer Res July 1 2019 (79) (13 Supplement) 2058, PMID: 32093809).|
|unspecified immune checkpoint inhibitor||CTLA4 Antibody 20 Immune Checkpoint Inhibitor 141 PD-L1/PD-1 antibody 83|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|